"Bulletin","Class_of_antibiotics","Antibiotic","Isolated","Resistance","95_IC_low","95_IC_upper"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2022.pdf","Penicilline","Ampicillina",8040,"1.0","0.8","1.3"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2022.pdf","Aminoglicosidi (alto dosaggio)","Gentamicina",3549,"34.0","32.5","35.6"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2022.pdf","Aminoglicosidi (alto dosaggio)","Streptomicina",4436,"32.0","30.6","33.4"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2022.pdf","Glicopeptidi","Vancomicina",7962,"2.0","1.7","2.3"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2022.pdf","Glicopeptidi","Glicopeptidi",7876,"2.1","1.8","2.5"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2022.pdf","Ossazolidinoni","Linezolid",7690,"0.6","0.4","0.8"
